350 related articles for article (PubMed ID: 16207189)
1. Iatrogenic calcinosis cutis following nadroparin injection.
Giorgini S; Martinelli C; Massi D; Lumini A; Mannucci M; Giglioli L
Int J Dermatol; 2005 Oct; 44(10):855-7. PubMed ID: 16207189
[TBL] [Abstract][Full Text] [Related]
2. An unusual adverse effect of nadroparin injections: Calcinosis cutis.
Nuno-Gonzalez A; Calzado-Villarreal L; Gutierrez-Pascual M; Gamo-Villegas R; Sanz-Robles H; Sanchez-Gilo A; Pinedo-Moraleda F; Lopez-Estebaranz JL
Dermatol Online J; 2011 Nov; 17(11):4. PubMed ID: 22136860
[TBL] [Abstract][Full Text] [Related]
3. Calcifying panniculitis following subcutaneous injections of nadroparin-calcium in a patient with osteomalacia.
Campanelli A; Kaya G; Masouyé I; Borradori L
Br J Dermatol; 2005 Sep; 153(3):657-60. PubMed ID: 16120161
[TBL] [Abstract][Full Text] [Related]
4. Nadroparin-induced Calcinosis cutis in renal transplant recipients.
van Haren FM; Ruiter DJ; Hilbrands LB
Nephron; 2001 Mar; 87(3):279-82. PubMed ID: 11287765
[TBL] [Abstract][Full Text] [Related]
5. Calcinosis of the cutis and subcutis: an unusual nonimmunologic adverse reaction to subcutaneous injections of low-molecular-weight calcium-containing heparins.
Eich D; Scharffetter-Kochanek K; Weihrauch J; Krieg T; Hunzelmann N
J Am Acad Dermatol; 2004 Feb; 50(2):210-4. PubMed ID: 14726874
[TBL] [Abstract][Full Text] [Related]
6. A patient with cutaneous lesions after liver transplantation.
Olde Bekkink M; Diercks GF; van den Berg AP; Tack CJ
Neth J Med; 2013 Jan; 71(1):34-7. PubMed ID: 23412823
[No Abstract] [Full Text] [Related]
7. Iatrogenic calcinosis cutis after subcutaneous LMW-heparin administration in a hemodialysis patient.
Bulatovic A; Schlieper G; Stankovic-Popovic V; Vujic D; Floege J; Dimkovic N
Int Urol Nephrol; 2013 Aug; 45(4):1239-41. PubMed ID: 23568661
[No Abstract] [Full Text] [Related]
8. [Two cases of iatrogenic cutis and subcutis calcinosis after calcium-containing heparin injection].
Bonnecarrère L; Templier I; Carron PL; Maurizi J; Salameire D; Beani JC; Blaise S
J Mal Vasc; 2009 Nov; 34(5):366-71. PubMed ID: 19782485
[TBL] [Abstract][Full Text] [Related]
9. Calcinosis cutis: a rare reaction to subcutaneous injections of calcium-containing heparin in patients with renal failure.
Boccara O; Prost-Squarcioni C; Battistella M; Brousse N; Rongioletti F; Fraitag S
Am J Dermatopathol; 2010 Feb; 32(1):52-5. PubMed ID: 19851086
[TBL] [Abstract][Full Text] [Related]
10. [Calcified subcutaneous nodules in patients with chronic renal failure as a result of injections with nadroparin (Fraxiparine)].
Wanic-Kossowska M; Kozioł L; Roszkowiak B; Lacka M; Frankiewicz D; Mandel M
Pol Arch Med Wewn; 1998 May; 99(5):414-6. PubMed ID: 9816892
[TBL] [Abstract][Full Text] [Related]
11. Incidental idiopathic calcinosis cutis in a rhytidectomy patient.
Aksoy HM; Ozdemir R; Karaaslan O; Tiftikcioglu YO; Oruç M; Koçer U
Dermatol Surg; 2004 Aug; 30(8):1145-7. PubMed ID: 15274707
[TBL] [Abstract][Full Text] [Related]
12. Dystrophic calcinosis cutis in pseudoxanthoma elasticum.
Federico A; Weinel S; Fabre V; Callen JP
J Am Acad Dermatol; 2008 Apr; 58(4):707-10. PubMed ID: 18342721
[TBL] [Abstract][Full Text] [Related]
13. Differences in the safety profiles of two low-molecular-weight heparins.
Ofosu FA
Thromb Haemost; 2008 Jun; 99(6):989-90. PubMed ID: 18521496
[No Abstract] [Full Text] [Related]
14. The effect of low molecular weight heparin on survival in patients with advanced malignancy.
Klerk CP; Smorenburg SM; Otten HM; Lensing AW; Prins MH; Piovella F; Prandoni P; Bos MM; Richel DJ; van Tienhoven G; Büller HR
J Clin Oncol; 2005 Apr; 23(10):2130-5. PubMed ID: 15699479
[TBL] [Abstract][Full Text] [Related]
15. Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. The Association of Non-University Affiliated Intensive Care Specialist Physicians of France.
Fraisse F; Holzapfel L; Couland JM; Simonneau G; Bedock B; Feissel M; Herbecq P; Pordes R; Poussel JF; Roux L
Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1109-14. PubMed ID: 10764298
[TBL] [Abstract][Full Text] [Related]
16. Calcinosis Cutis Caused by Subcutaneous Injection of Calcium-containing Heparin in a Patient with Systemic Lupus Erythematosus.
Hattori M; Shimizu A; Ishikawa O
Acta Derm Venereol; 2018 Jun; 98(6):614-615. PubMed ID: 29881870
[No Abstract] [Full Text] [Related]
17. Calcinosis cutis following electromyographic examination.
Johnson RC; Fitzpatrick JE; Hahn DE
Cutis; 1993 Sep; 52(3):161-4. PubMed ID: 8243099
[TBL] [Abstract][Full Text] [Related]
18. Calcinosis cutis complicating liver transplantation.
Ehsani AH; Abedini R; Ghiasi M; Hoseini MS
Dermatol Online J; 2006 Dec; 12(7):23. PubMed ID: 17459309
[TBL] [Abstract][Full Text] [Related]
19. Two cases of gigantic dystrophic calcinosis cutis caused by subcutaneous and/or intramuscular injections.
Kanda A; Uchimiya H; Ohtake N; Setoyama M; Kanzaki T
J Dermatol; 1999 Jun; 26(6):371-4. PubMed ID: 10405483
[TBL] [Abstract][Full Text] [Related]
20. Prevention of deep-vein thrombosis after total knee replacement. Randomised comparison between a low-molecular-weight heparin (nadroparin) and mechanical prophylaxis with a foot-pump system.
Blanchard J; Meuwly JY; Leyvraz PF; Miron MJ; Bounameaux H; Hoffmeyer P; Didier D; Schneider PA
J Bone Joint Surg Br; 1999 Jul; 81(4):654-9. PubMed ID: 10463739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
